158 related articles for article (PubMed ID: 36332495)
1. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins.
Parma B; Wurdak H; Ceppi P
Drug Resist Updat; 2022 Dec; 65():100888. PubMed ID: 36332495
[TBL] [Abstract][Full Text] [Related]
2. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.
Parma B; Ramesh V; Gollavilli PN; Siddiqui A; Pinna L; Schwab A; Marschall S; Zhang S; Pilarsky C; Napoli F; Volante M; Urbanczyk S; Mielenz D; Schrøder HD; Stemmler M; Wurdak H; Ceppi P
J Exp Clin Cancer Res; 2021 Aug; 40(1):248. PubMed ID: 34364401
[TBL] [Abstract][Full Text] [Related]
3. Heat Shock Proteins in Non-Small-Cell Lung Cancer-Functional Mechanism.
Zhou G; Pu Y; Zhao K; Chen Y; Zhang G
Front Biosci (Landmark Ed); 2023 Mar; 28(3):56. PubMed ID: 37005758
[TBL] [Abstract][Full Text] [Related]
4. 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer.
Mulati S; Jiang R; Wang J; Tao Y; Zhang W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429106
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
6. Heat shock proteins as biomarkers of lung cancer.
Mittal S; Rajala MS
Cancer Biol Ther; 2020 Jun; 21(6):477-485. PubMed ID: 32228356
[TBL] [Abstract][Full Text] [Related]
7. HSP90 inhibitors in lung cancer: promise still unfulfilled.
Chatterjee S; Bhattacharya S; Socinski MA; Burns TF
Clin Adv Hematol Oncol; 2016 May; 14(5):346-56. PubMed ID: 27379696
[TBL] [Abstract][Full Text] [Related]
8. Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells.
Tiong TY; Weng PW; Wang CH; Setiawan SA; Yadav VK; Pikatan NW; Fong IH; Yeh CT; Hsu CH; Kuo KT
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806291
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients.
Tang Y; Yang Y; Luo J; Liu S; Zhan Y; Zang H; Zheng H; Zhang Y; Feng J; Fan S; Wen Q
Cancer Biomark; 2021; 30(1):85-94. PubMed ID: 32986659
[TBL] [Abstract][Full Text] [Related]
10. Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy.
Yun CW; Kim HJ; Lim JH; Lee SH
Cells; 2019 Dec; 9(1):. PubMed ID: 31878360
[TBL] [Abstract][Full Text] [Related]
11. Exploiting metabolic vulnerabilities of Non small cell lung carcinoma.
Majem B; Nadal E; Muñoz-Pinedo C
Semin Cell Dev Biol; 2020 Feb; 98():54-62. PubMed ID: 31238096
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
[TBL] [Abstract][Full Text] [Related]
13. Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling.
Zhang Y; Qiu F; Ye T; Lee SH; Xu J; Jia L; Zeng R; Wang X; Hu X; Yan X; Li H; Lu Y; Wang X; Jiang R; Xu W
Stem Cell Res Ther; 2022 May; 13(1):197. PubMed ID: 35551652
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer.
Saini J; Sharma PK
Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C
J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814
[TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Hsu PC; Jablons DM; Yang CT; You L
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
[TBL] [Abstract][Full Text] [Related]
17. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.
Thiagarajan PS; Wu X; Zhang W; Shi I; Bagai R; Leahy P; Feng Y; Veigl M; Lindner D; Danielpour D; Yin L; Rosell R; Bivona TG; Zhang Z; Ma PC
Oncotarget; 2016 Dec; 7(50):82013-82027. PubMed ID: 27852038
[TBL] [Abstract][Full Text] [Related]
19. Ins and Outs of Heat Shock Proteins in Colorectal Carcinoma: Its Role in Carcinogenesis and Therapeutic Perspectives.
Abi Zamer B; El-Huneidi W; Eladl MA; Muhammad JS
Cells; 2021 Oct; 10(11):. PubMed ID: 34831085
[TBL] [Abstract][Full Text] [Related]
20. Expression of heat shock protein 70 and 27 in non-small cell lung cancer and its clinical significance.
Huang Q; Zu Y; Fu X; Wu T
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):693-5. PubMed ID: 16696328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
